Applied Bioenergetics Lab at Faculty of Sport and PE
Novi Sad, Vojvodina, 21000, Serbia
NCT Number: NCT02830854
A variety of non-pharmacological interventions have been used in the management of Alzheimer's disease (AD) and similar cognitive disorders in elderly, yet no therapeutic modality has demonstrated conclusive positive results in terms of effectiveness. Although it is still unknown what triggers AD, recent studies have shown that AD is associated with brain energy depletion, oxidative stress, and mitochondrial dysfunction. Since supplemental molecular hydrogen (H2) supports cell energy production and acts as a highly bioavailable mitochondria-related antioxidant, it may provide an ideal agent to facilitate treatment and perhaps prevention of AD and similar cognitive disorders in elderly. The overall hypothesis to be evaluated in this project is that administration of H2 will positively affect patient-reported outcomes and clinical biomarkers in men and women suffering from AD.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Phase 3
Novi Sad, Vojvodina, 21000, Serbia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Change from Baseline ADAS-Cog Score at 4 weeks
ADAS-Cog total score and scores for 4 separate cognitive domains (memory, orientation, praxis, and language) will be evaluated.
University of Novi Sad, Faculty of Sport and Physical Education
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01071044
Chronic Disease, Chronic Fatigue Syndrome
Rochester Hills, Michigan, United States
View Trial DetailsNCT07069530
Alzheimer Disease, Alzheimer Disease (AD)
Fort Myers, Florida, United States
View Trial DetailsNCT07029048
COVID 19, COVID-19
Astana, Kazakhstan
View Trial DetailsNCT05822596
Cognition Disorders, Cognitive Dysfunction
Hong Kong
View Trial Details